Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 061655
Company: APOTHECON

Products on ANDA 061655

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
KANTREX	KANAMYCIN SULFATE	EQ 500MG BASE/2ML	INJECTABLE;INJECTION	Discontinued	None	No	No
KANTREX	KANAMYCIN SULFATE	EQ 1GM BASE/3ML	INJECTABLE;INJECTION	Discontinued	None	No	No
KANTREX	KANAMYCIN SULFATE	EQ 75MG BASE/2ML	INJECTABLE;INJECTION	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 061655

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/13/1973	ORIG-1	Approval				Label is not available on this site.